Novo Nordisk A/S (NYSE:NVO)

47.73
Delayed Data
As of May 25
 -0.37 / -0.77%
Today’s Change
41.03
Today|||52-Week Range
58.37
-11.07%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Revenue and IncomeNet Revenues15.7B16.0B16.6B17.1B
 
 
 
 
 
Cost of Goods Sold2.2B2.1B2.2B2.4B
 
 
 
 
 
Depreciation And Amortization495.6M387.4M393.1M439.7M
 
 
 
 
 
 
Operating ExpensesGross Income13.1B13.5B13.9B14.3B
 
 
 
 
 
General Expenses7.0B6.7B6.8B6.9B
 
 
 
 
 
Other Operating Expenses113.3M0.000.000.00
 
 
Research And Development2.3B1.9B2.0B2.0B
 
 
 
 
 
Total Operating Expenses9.8B9.1B9.4B9.7B
 
 
 
 
 
 
Non-Operating ExpensesOperating Income6.0B6.8B7.2B7.4B
 
 
 
 
 
Extraordinary Credit0.000.000.00397.2M
 
 
Extraordinary Charge-321.0M-848.2M-116.1M-352.4M
 
 
 
 
 
Interest Expense On Debt26.6M21.9M22.2M24.2M
 
 
 
 
 
Equity In Earnings0.002.1M3.6M2.1M
 
 
 
 
Other Expenses418.3M447.8M63.9M36.0M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income6.0B6.4B7.1B7.5B
 
 
 
 
 
Income Taxes-1.3B-1.3B-1.5B-1.6B
 
 
 
 
 
Net Income4.7B5.2B5.6B5.8B
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS2.6B2.6B2.5B2.5B
 
 
 
 
 
Shares To Calculate EPS Diluted2.6B2.6B2.5B2.5B
 
 
 
 
 
 
Earnings Per ShareEPS$1.79$2.01$2.22--
 
 
 
 
EPS Diluted$1.78$2.00$2.22$2.36